Jiangsu Nanfang Medical (603880) - Total Liabilities

Latest as of March 2026: CN¥736.45 Million CNY ≈ $107.77 Million USD

Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has total liabilities worth CN¥736.45 Million CNY (≈ $107.77 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Jiangsu Nanfang Medical - Total Liabilities Trend (2012–2025)

This chart illustrates how Jiangsu Nanfang Medical's total liabilities have evolved over time, based on quarterly financial data. See Jiangsu Nanfang Medical (603880) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Jiangsu Nanfang Medical Competitors by Total Liabilities

The table below lists competitors of Jiangsu Nanfang Medical ranked by their total liabilities.

Company	Country	Total Liabilities
Green Cross KO:005250	Korea	₩2.40 Trillion
PCB Bancorp NASDAQ:PCB	USA	$2.89 Billion
Strattec Security Corporation NASDAQ:STRT	USA	$132.39 Million
Ausgold Ltd AU:AUC	Australia	AU$23.51 Million
LINKBANCORP Inc NASDAQ:LNKB	USA	$2.76 Billion
Founders Metals Inc. V:FDR	Canada	CA$8.87 Million
Citizens Financial Services Inc. Common Stock NASDAQ:CZFS	USA	$2.68 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Jiangsu Nanfang Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Jiangsu Nanfang Medical worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	4.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.81	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Nanfang Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Nanfang Medical (2012–2025)

The table below shows the annual total liabilities of Jiangsu Nanfang Medical from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥746.77 Million ≈ $109.28 Million	-3.29%
2024-12-31	CN¥772.14 Million ≈ $112.99 Million	-3.86%
2023-12-31	CN¥803.11 Million ≈ $117.52 Million	-3.91%
2022-12-31	CN¥835.75 Million ≈ $122.30 Million	+44.02%
2021-12-31	CN¥580.29 Million ≈ $84.92 Million	+56.06%
2020-12-31	CN¥371.84 Million ≈ $54.41 Million	+23.09%
2019-12-31	CN¥302.08 Million ≈ $44.20 Million	+5.70%
2018-12-31	CN¥285.78 Million ≈ $41.82 Million	+0.13%
2017-12-31	CN¥285.40 Million ≈ $41.76 Million	+9.82%
2016-12-31	CN¥259.87 Million ≈ $38.03 Million	+3.59%
2015-12-31	CN¥250.86 Million ≈ $36.71 Million	+10.95%
2014-12-31	CN¥226.10 Million ≈ $33.09 Million	+10.41%
2013-12-31	CN¥204.78 Million ≈ $29.97 Million	-20.75%
2012-12-31	CN¥258.41 Million ≈ $37.81 Million	--

About Jiangsu Nanfang Medical

SHG:603880 China Medical Instruments & Supplies

Market Cap

$325.68 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14518 Global

#4333 in China

Share Price

CN¥7.70

Change (1 day)

-4.47%

52-Week Range

CN¥5.88 - CN¥8.76

All Time High

CN¥16.80